What is ERNA's dilution risk score?

ERNA has a latest available DilutionScore record of 100/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ERNA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ERNA?

DilutionWatch tracks 25 SEC filing types for ERNA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ERNA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ERNA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ERNA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ERNA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ERNA Dilution Risk Score: 100/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

85

📊 Float Risk

57

⚠️ Warrant Exposure

90

🔄 Convertible Debt

85

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 66%

💰 Capital Raise model 73%

• Low cash runway: 4 months remaining

• Active shelf registration ($50M, 406% of market cap)

📜 Warrant Exercise model 60%

• Massive warrant overhang: 374% of shares outstanding

• Warrant risk score very high (90/100)

🔁 Convertible Conversion model 60%

• Major convertible overhang: 260% potential dilution

• Convertible risk score very high (85/100)

🔔 Track ERNA — Get forecast alerts →

Market Data

Market Cap$12.33M

Shares Outstanding1.63M

Float818.1K

Cash$4.32M

Debt$2.03M

Short InterestN/A

Institutional Holdings

10 institutional holders · 26.0K shares

#1 Corient Private Wealth LLC 17.5K shares

#2 Warberg Asset Management LLC 2.0K shares

#3 Jane Street Group, LLC 1.6K shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest14.6K

Days to Cover1.0

% of Float1.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2024-12-31

EFFECT EFFECT 2026-03-30

S-3/A SHELF 2026-03-24

S-3 SHELF 2026-03-16

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ERNA Dilution Snapshot

Ernexa Therapeutics Inc. (ERNA) has a DilutionScore of 100/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $50.0M.
Stored ATM program remaining capacity: $10.0M.
Stored outstanding warrants: 6.1M.
Recent SEC activity tracked for ERNA: EFFECT on 2026-03-30; S-3/A on 2026-03-24; S-3 on 2026-03-16.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.